Teresa V Brown, DO - Medicare Endocrinology in New Providence, NJ

Teresa V Brown, DO is a medicare enrolled "Internal Medicine - Endocrinology, Diabetes & Metabolism" physician in New Providence, New Jersey. She went to Philadelphia Col Of Osteo Med, Sewanee and graduated in 2013 and has 11 years of diverse experience with area of expertise as Endocrinology. She is a member of the group practice Rwjbh Emergency Medicine Associates, Llc, Rutgers Health-rwj Pediatric Critical Care, Icahn School Of Medicine At Mount Sinai and her current practice location is 890 Mountain Ave, New Providence, New Jersey. You can reach out to her office (for appointments etc.) via phone at (908) 277-8667.

Teresa V Brown is licensed to practice in New Jersey (license number 25MB09922900) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1194117127.

Contact Information

Teresa V Brown, DO
890 Mountain Ave,
New Providence, NJ 07974-1218
(908) 277-8667
(908) 277-8707



Physician's Profile

Full NameTeresa V Brown
GenderFemale
SpecialityEndocrinology
Experience11 Years
Location890 Mountain Ave, New Providence, New Jersey
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Teresa V Brown attended and graduated from Philadelphia Col Of Osteo Med, Sewanee in 2013
  NPI Data:
  • NPI Number: 1194117127
  • Provider Enumeration Date: 02/27/2015
  • Last Update Date: 10/14/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 5496035784
  • Enrollment ID: I20161202000245

Medical Identifiers

Medical identifiers for Teresa V Brown such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1194117127NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208M00000XHospitalist 318694 (New York)Secondary
207RE0101XInternal Medicine - Endocrinology, Diabetes & Metabolism 25MB09922900 (New Jersey)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Mount Sinai St Luke's Roosevelt HospitalNew york, NYHospital
Robert Wood Johnson University HospitalNew brunswick, NJHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Rwjbh Emergency Medicine Associates, Llc0941612840613
Rutgers Health-rwj Pediatric Critical Care1355390287143
Icahn School Of Medicine At Mount Sinai22646910702339

News Archive

Midland hospitals claim victory against MRSA superbug

Reports reveal that Midland hospitals have won the war against the killer superbug Methicillin-resistant Staphylococcus aureus (MRSA) and some NHS trusts have completely eradicated the disease. The infection was hitting more than a thousand vulnerable patients in the region every year at its peak in 2004 and 2005, leading to many deaths.

The stakes are high for the top Medicare job

Reuters reports that health care overhaul currently being considered in Congress "elevates the job of running the government's $700-billion Medicare agency to new heights and all but guarantees a political battle over filling the post."

VHIO-born spin-off receives approval to initiate Phase I/II clinical trial of novel Myc inhibitor

Co-founded back in 2014 by VHIO's Laura Soucek, CEO of the enterprise, and Marie-Eve Beaulieu, Chief Scientific Officer (CSO) of the company, VHIO-born spin-off Peptomyc S.L. has just announced that it has received approval from the Spanish Agency of Medicines and Medical Devices for conducting clinical trials in Spain (AEMPS), to initiate the first-in-human Phase I/II clinical trial with its first compound - a disruptive Myc inhibitor, Omomyc (OMO-103).

Unsatisfied Chinese Americans' expectations lead to increased mortality risks

Filial piety - the traditional value of caring for one's elders - is foundational to the Chinese concept of family and greatly influences intergenerational relationships.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Teresa V Brown allows following entities to bill medicare on her behalf.
Entity NameSummit Medical Group Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1942254347
PECOS PAC ID: 5395642276
Enrollment ID: O20031218000011

News Archive

Midland hospitals claim victory against MRSA superbug

Reports reveal that Midland hospitals have won the war against the killer superbug Methicillin-resistant Staphylococcus aureus (MRSA) and some NHS trusts have completely eradicated the disease. The infection was hitting more than a thousand vulnerable patients in the region every year at its peak in 2004 and 2005, leading to many deaths.

The stakes are high for the top Medicare job

Reuters reports that health care overhaul currently being considered in Congress "elevates the job of running the government's $700-billion Medicare agency to new heights and all but guarantees a political battle over filling the post."

VHIO-born spin-off receives approval to initiate Phase I/II clinical trial of novel Myc inhibitor

Co-founded back in 2014 by VHIO's Laura Soucek, CEO of the enterprise, and Marie-Eve Beaulieu, Chief Scientific Officer (CSO) of the company, VHIO-born spin-off Peptomyc S.L. has just announced that it has received approval from the Spanish Agency of Medicines and Medical Devices for conducting clinical trials in Spain (AEMPS), to initiate the first-in-human Phase I/II clinical trial with its first compound - a disruptive Myc inhibitor, Omomyc (OMO-103).

Unsatisfied Chinese Americans' expectations lead to increased mortality risks

Filial piety - the traditional value of caring for one's elders - is foundational to the Chinese concept of family and greatly influences intergenerational relationships.

Read more Medical News

› Verified 6 days ago

Entity NameAtlanticare Physician Group Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1093829608
PECOS PAC ID: 8527953660
Enrollment ID: O20040218000405

News Archive

Midland hospitals claim victory against MRSA superbug

Reports reveal that Midland hospitals have won the war against the killer superbug Methicillin-resistant Staphylococcus aureus (MRSA) and some NHS trusts have completely eradicated the disease. The infection was hitting more than a thousand vulnerable patients in the region every year at its peak in 2004 and 2005, leading to many deaths.

The stakes are high for the top Medicare job

Reuters reports that health care overhaul currently being considered in Congress "elevates the job of running the government's $700-billion Medicare agency to new heights and all but guarantees a political battle over filling the post."

VHIO-born spin-off receives approval to initiate Phase I/II clinical trial of novel Myc inhibitor

Co-founded back in 2014 by VHIO's Laura Soucek, CEO of the enterprise, and Marie-Eve Beaulieu, Chief Scientific Officer (CSO) of the company, VHIO-born spin-off Peptomyc S.L. has just announced that it has received approval from the Spanish Agency of Medicines and Medical Devices for conducting clinical trials in Spain (AEMPS), to initiate the first-in-human Phase I/II clinical trial with its first compound - a disruptive Myc inhibitor, Omomyc (OMO-103).

Unsatisfied Chinese Americans' expectations lead to increased mortality risks

Filial piety - the traditional value of caring for one's elders - is foundational to the Chinese concept of family and greatly influences intergenerational relationships.

Read more Medical News

› Verified 6 days ago

Entity NameClinical Health Care Associates Of New Jersey Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1447260435
PECOS PAC ID: 0749180198
Enrollment ID: O20040421001473

News Archive

Midland hospitals claim victory against MRSA superbug

Reports reveal that Midland hospitals have won the war against the killer superbug Methicillin-resistant Staphylococcus aureus (MRSA) and some NHS trusts have completely eradicated the disease. The infection was hitting more than a thousand vulnerable patients in the region every year at its peak in 2004 and 2005, leading to many deaths.

The stakes are high for the top Medicare job

Reuters reports that health care overhaul currently being considered in Congress "elevates the job of running the government's $700-billion Medicare agency to new heights and all but guarantees a political battle over filling the post."

VHIO-born spin-off receives approval to initiate Phase I/II clinical trial of novel Myc inhibitor

Co-founded back in 2014 by VHIO's Laura Soucek, CEO of the enterprise, and Marie-Eve Beaulieu, Chief Scientific Officer (CSO) of the company, VHIO-born spin-off Peptomyc S.L. has just announced that it has received approval from the Spanish Agency of Medicines and Medical Devices for conducting clinical trials in Spain (AEMPS), to initiate the first-in-human Phase I/II clinical trial with its first compound - a disruptive Myc inhibitor, Omomyc (OMO-103).

Unsatisfied Chinese Americans' expectations lead to increased mortality risks

Filial piety - the traditional value of caring for one's elders - is foundational to the Chinese concept of family and greatly influences intergenerational relationships.

Read more Medical News

› Verified 6 days ago

Entity NameRutgers Health-rwj Family Medicine
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1780766527
PECOS PAC ID: 9032174271
Enrollment ID: O20041130000005

News Archive

Midland hospitals claim victory against MRSA superbug

Reports reveal that Midland hospitals have won the war against the killer superbug Methicillin-resistant Staphylococcus aureus (MRSA) and some NHS trusts have completely eradicated the disease. The infection was hitting more than a thousand vulnerable patients in the region every year at its peak in 2004 and 2005, leading to many deaths.

The stakes are high for the top Medicare job

Reuters reports that health care overhaul currently being considered in Congress "elevates the job of running the government's $700-billion Medicare agency to new heights and all but guarantees a political battle over filling the post."

VHIO-born spin-off receives approval to initiate Phase I/II clinical trial of novel Myc inhibitor

Co-founded back in 2014 by VHIO's Laura Soucek, CEO of the enterprise, and Marie-Eve Beaulieu, Chief Scientific Officer (CSO) of the company, VHIO-born spin-off Peptomyc S.L. has just announced that it has received approval from the Spanish Agency of Medicines and Medical Devices for conducting clinical trials in Spain (AEMPS), to initiate the first-in-human Phase I/II clinical trial with its first compound - a disruptive Myc inhibitor, Omomyc (OMO-103).

Unsatisfied Chinese Americans' expectations lead to increased mortality risks

Filial piety - the traditional value of caring for one's elders - is foundational to the Chinese concept of family and greatly influences intergenerational relationships.

Read more Medical News

› Verified 6 days ago

Entity NameRutgers Health-rwj Pediatric Critical Care
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1780766527
PECOS PAC ID: 1355390287
Enrollment ID: O20050119000070

News Archive

Midland hospitals claim victory against MRSA superbug

Reports reveal that Midland hospitals have won the war against the killer superbug Methicillin-resistant Staphylococcus aureus (MRSA) and some NHS trusts have completely eradicated the disease. The infection was hitting more than a thousand vulnerable patients in the region every year at its peak in 2004 and 2005, leading to many deaths.

The stakes are high for the top Medicare job

Reuters reports that health care overhaul currently being considered in Congress "elevates the job of running the government's $700-billion Medicare agency to new heights and all but guarantees a political battle over filling the post."

VHIO-born spin-off receives approval to initiate Phase I/II clinical trial of novel Myc inhibitor

Co-founded back in 2014 by VHIO's Laura Soucek, CEO of the enterprise, and Marie-Eve Beaulieu, Chief Scientific Officer (CSO) of the company, VHIO-born spin-off Peptomyc S.L. has just announced that it has received approval from the Spanish Agency of Medicines and Medical Devices for conducting clinical trials in Spain (AEMPS), to initiate the first-in-human Phase I/II clinical trial with its first compound - a disruptive Myc inhibitor, Omomyc (OMO-103).

Unsatisfied Chinese Americans' expectations lead to increased mortality risks

Filial piety - the traditional value of caring for one's elders - is foundational to the Chinese concept of family and greatly influences intergenerational relationships.

Read more Medical News

› Verified 6 days ago

Entity NamePractice Associates Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1427016385
PECOS PAC ID: 5890703177
Enrollment ID: O20060330000690

News Archive

Midland hospitals claim victory against MRSA superbug

Reports reveal that Midland hospitals have won the war against the killer superbug Methicillin-resistant Staphylococcus aureus (MRSA) and some NHS trusts have completely eradicated the disease. The infection was hitting more than a thousand vulnerable patients in the region every year at its peak in 2004 and 2005, leading to many deaths.

The stakes are high for the top Medicare job

Reuters reports that health care overhaul currently being considered in Congress "elevates the job of running the government's $700-billion Medicare agency to new heights and all but guarantees a political battle over filling the post."

VHIO-born spin-off receives approval to initiate Phase I/II clinical trial of novel Myc inhibitor

Co-founded back in 2014 by VHIO's Laura Soucek, CEO of the enterprise, and Marie-Eve Beaulieu, Chief Scientific Officer (CSO) of the company, VHIO-born spin-off Peptomyc S.L. has just announced that it has received approval from the Spanish Agency of Medicines and Medical Devices for conducting clinical trials in Spain (AEMPS), to initiate the first-in-human Phase I/II clinical trial with its first compound - a disruptive Myc inhibitor, Omomyc (OMO-103).

Unsatisfied Chinese Americans' expectations lead to increased mortality risks

Filial piety - the traditional value of caring for one's elders - is foundational to the Chinese concept of family and greatly influences intergenerational relationships.

Read more Medical News

› Verified 6 days ago

Entity NameRwjbh Emergency Medicine Associates, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1912510041
PECOS PAC ID: 0941612840
Enrollment ID: O20201217002547

News Archive

Midland hospitals claim victory against MRSA superbug

Reports reveal that Midland hospitals have won the war against the killer superbug Methicillin-resistant Staphylococcus aureus (MRSA) and some NHS trusts have completely eradicated the disease. The infection was hitting more than a thousand vulnerable patients in the region every year at its peak in 2004 and 2005, leading to many deaths.

The stakes are high for the top Medicare job

Reuters reports that health care overhaul currently being considered in Congress "elevates the job of running the government's $700-billion Medicare agency to new heights and all but guarantees a political battle over filling the post."

VHIO-born spin-off receives approval to initiate Phase I/II clinical trial of novel Myc inhibitor

Co-founded back in 2014 by VHIO's Laura Soucek, CEO of the enterprise, and Marie-Eve Beaulieu, Chief Scientific Officer (CSO) of the company, VHIO-born spin-off Peptomyc S.L. has just announced that it has received approval from the Spanish Agency of Medicines and Medical Devices for conducting clinical trials in Spain (AEMPS), to initiate the first-in-human Phase I/II clinical trial with its first compound - a disruptive Myc inhibitor, Omomyc (OMO-103).

Unsatisfied Chinese Americans' expectations lead to increased mortality risks

Filial piety - the traditional value of caring for one's elders - is foundational to the Chinese concept of family and greatly influences intergenerational relationships.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Teresa V Brown is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Teresa V Brown, DO
890 Mountain Ave,
New Providence, NJ 07974-1218

Ph: (908) 277-8667
Teresa V Brown, DO
890 Mountain Ave,
New Providence, NJ 07974-1218

Ph: (908) 277-8667

News Archive

Midland hospitals claim victory against MRSA superbug

Reports reveal that Midland hospitals have won the war against the killer superbug Methicillin-resistant Staphylococcus aureus (MRSA) and some NHS trusts have completely eradicated the disease. The infection was hitting more than a thousand vulnerable patients in the region every year at its peak in 2004 and 2005, leading to many deaths.

The stakes are high for the top Medicare job

Reuters reports that health care overhaul currently being considered in Congress "elevates the job of running the government's $700-billion Medicare agency to new heights and all but guarantees a political battle over filling the post."

VHIO-born spin-off receives approval to initiate Phase I/II clinical trial of novel Myc inhibitor

Co-founded back in 2014 by VHIO's Laura Soucek, CEO of the enterprise, and Marie-Eve Beaulieu, Chief Scientific Officer (CSO) of the company, VHIO-born spin-off Peptomyc S.L. has just announced that it has received approval from the Spanish Agency of Medicines and Medical Devices for conducting clinical trials in Spain (AEMPS), to initiate the first-in-human Phase I/II clinical trial with its first compound - a disruptive Myc inhibitor, Omomyc (OMO-103).

Unsatisfied Chinese Americans' expectations lead to increased mortality risks

Filial piety - the traditional value of caring for one's elders - is foundational to the Chinese concept of family and greatly influences intergenerational relationships.

Read more News

› Verified 6 days ago


Internal Medicine Doctors in New Providence, NJ

Dr. Khimya I Vaswani, MD
Endocrinology, Diabetes & Metabolism
Medicare: Not Enrolled in Medicare
Practice Location: 1806 Springfield Ave, New Providence, NJ 07974
Phone: 973-912-0104    Fax: 973-376-7040
Robert John Mich, MD
Endocrinology, Diabetes & Metabolism
Medicare: Not Enrolled in Medicare
Practice Location: 571 Central Ave Ste 115, Associates In Cardiovascular Disease Llc, New Providence, NJ 07974
Phone: 908-464-4200    Fax: 908-464-1332
John Patrick Farry, MD
Endocrinology, Diabetes & Metabolism
Medicare: Accepting Medicare Assignments
Practice Location: 571 Central Ave Ste 115, Associates In Cardiovascular Disease Llc, New Providence, NJ 07974
Phone: 908-464-4200    Fax: 908-464-1332
Robert L Rosenbaum, MD
Endocrinology, Diabetes & Metabolism
Medicare: Accepting Medicare Assignments
Practice Location: 890 Mountain Ave, New Providence, NJ 07974
Phone: 908-277-8667    Fax: 908-277-8707
Dr. James John Hakim, MD
Endocrinology, Diabetes & Metabolism
Medicare: Accepting Medicare Assignments
Practice Location: 571 Central Ave Ste 112, New Providence, NJ 07974
Phone: 908-464-7300    Fax: 908-464-7350
David Bartov, MD
Endocrinology, Diabetes & Metabolism
Medicare: Accepting Medicare Assignments
Practice Location: 571 Central Ave Ste 115, Associates In Cardiovascular Disease, New Providence, NJ 07974
Phone: 908-464-2000    Fax: 908-464-1332
Dr. Sushmita Srivastav, MD
Endocrinology, Diabetes & Metabolism
Medicare: Accepting Medicare Assignments
Practice Location: 535 Mountain Ave, New Providence, NJ 07974
Phone: 903-516-9245    Fax: 908-516-9265

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.